Medinotec (MDNC) Net Income towards Common Stockholders (QoQ) (2022 - 2026)
Medinotec (MDNC) Net Income towards Common Stockholders (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -57.88% |
| Feb 28, 2026 | 101.25% |
| Nov 30, 2025 | -66.34% |
| Aug 31, 2025 | 39.03% |
| May 31, 2025 | -87.86% |
| Feb 28, 2025 | 1,202.55% |
| Nov 30, 2024 | 386.80% |
| Aug 31, 2024 | -136.88% |
| May 31, 2024 | -4.95% |
| Feb 29, 2024 | 167.16% |
| Nov 30, 2023 | -1,018.16% |
| Aug 31, 2023 | -339.97% |
| May 31, 2023 | -47.94% |
| Feb 28, 2023 | 60.49% |
| Nov 30, 2022 | 110.01% |
| Aug 31, 2022 | -2,671.46% |
| May 31, 2022 | 106.88% |